stockrowGlobus Medical, Inc.
GMED Healthcare Medical Devices
Globus Medical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 billion, up 16.7% from fiscal 2024.
- Revenue
- −0.69%
- EPS
- +19.3%
- Free cash flow
- +10.1%
Quarter to September 2026, against a year earlier
Follow GMED
Alert me
Globus Medical, Inc. (GMED) Net income
Globus Medical, Inc.'s net income for fiscal 2025 was $537.9M, up 422.3% from $103.0M in fiscal 2024. Over the twelve months to 30 September 2026 it was $557.6M. Over the past ten years it has ranged from $102.3M (fiscal 2020) to $537.9M (fiscal 2025) — the current reading is the highest in ten years. Globus Medical, Inc. ranks 14th of 149 Medical Devices companies by net income.
Net income, annual
Embed this chart
Annual newest first
| Period | Net income | Change |
|---|---|---|
| FY2025 | $537.9M | 422.28% |
| FY2024 | $103.0M | (16.19%) |
| FY2023 | $122.9M | (35.39%) |
| FY2022 | $190.2M | 27.47% |
| FY2021 | $149.2M | 45.86% |
| FY2020 | $102.3M | (34.10%) |
| FY2019 | $155.2M | (0.81%) |
| FY2018 | $156.5M | 45.76% |
| FY2017 | $107.3M | 2.88% |
| FY2016 | $104.3M | (7.49%) |
Quarterly newest first
| Period | Net income | Change |
|---|---|---|
| Sep 2026 | $141.2M | (6.86%) |
| Jun 2026 | $151.6M | 21.94% |
| Mar 2026 | $124.3M | (11.59%) |
| Dec 2025 | $140.6M | 18.18% |
| 43 more quarters | Free account |
Against its own ten years
Net income against peers
| Company | Net income |
|---|---|
| SNN Smith & Nephew SNATS, Inc. compare | $2.0B |
| BIO.B Bio-Rad Laboratories, Inc. compare | $616.6M |
| BIO Bio-Rad Laboratories, Inc. compare | $616.6M |
| GMED Globus Medical, Inc. | $557.6M |
| PODD Insulet Corporation compare | $428.8M |
| PEN Penumbra, Inc. compare | $157.0M |
| TXG 10x Genomics compare | −$75.1M |
| BRKR Bruker Corporation compare | −$115.7M |
| GKOS Glaukos Corporation compare | −$169.8M |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on GMED
- Revenue
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement